Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle E Mor

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Trends in Biochemical Sciences|March 7, 2024
Keeping neuronal activity in check: a novel role for α-synuclein serine-129 phosphorylation in the healthy brainDanielle E Mor
Journal of Experimental Neuroscience|March 22, 2018
The Convergence of Dopamine and α-Synuclein: Implications for Parkinson's DiseaseDanielle E Mor, Harry Ischiropoulos
International Journal of Molecular Sciences|April 28, 2023
Gut-to-Brain α-Synuclein Transmission in Parkinson's Disease: Evidence for Prion-like MechanismsMerry Chen, Danielle E Mor
Current Research in Microbial Sciences|September 29, 2025
Gut microbiome species <i>Levilactobacillus brevis</i> regulates reproductive fitness in <i>C. elegans</i>Nicole J Braun, Danielle E Mor
Translational Medicine of Aging|November 12, 2020
Mitochondrial hyperactivity as a potential therapeutic target in Parkinson's diseaseDanielle E Mor, Coleen T Murphy
Frontiers in Neuroscience|June 11, 2026
Toward common treatment strategies: convergent proteinopathies and mitochondrial dysfunction in Alzheimer's and Parkinson's diseasesJulie E V Offerdahl, Danielle E Mor
Movement Disorders : Official Journal of the Movement Disorder Society|January 12, 2019
The usual suspects, dopamine and alpha-synuclein, conspire to cause neurodegenerationDanielle E Mor, Malcolm J Daniels, Harry Ischiropoulos
Neurobiology of Disease|January 10, 2016
Dynamic structural flexibility of α-synucleinDanielle E Mor, Scott E Ugras, Malcolm J Daniels, et al.
Communications Biology|February 16, 2021
High-throughput behavioral screen in C. elegans reveals Parkinson's disease drug candidatesSalman Sohrabi, Danielle E Mor, Rachel Kaletsky, et al.
Life Science Alliance|July 5, 2022
Heparan sulfate proteoglycans mediate prion-like α-synuclein toxicity in Parkinson's in vivo modelsMerry Chen, Julie Vincent, Alexis Ezeanii, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Trends in Biochemical Sciences|March 7, 2024
Keeping neuronal activity in check: a novel role for α-synuclein serine-129 phosphorylation in the healthy brainDanielle E Mor
Journal of Experimental Neuroscience|March 22, 2018
The Convergence of Dopamine and α-Synuclein: Implications for Parkinson's DiseaseDanielle E Mor, Harry Ischiropoulos
International Journal of Molecular Sciences|April 28, 2023
Gut-to-Brain α-Synuclein Transmission in Parkinson's Disease: Evidence for Prion-like MechanismsMerry Chen, Danielle E Mor
Current Research in Microbial Sciences|September 29, 2025
Gut microbiome species <i>Levilactobacillus brevis</i> regulates reproductive fitness in <i>C. elegans</i>Nicole J Braun, Danielle E Mor
Translational Medicine of Aging|November 12, 2020
Mitochondrial hyperactivity as a potential therapeutic target in Parkinson's diseaseDanielle E Mor, Coleen T Murphy
Frontiers in Neuroscience|June 11, 2026
Toward common treatment strategies: convergent proteinopathies and mitochondrial dysfunction in Alzheimer's and Parkinson's diseasesJulie E V Offerdahl, Danielle E Mor
Movement Disorders : Official Journal of the Movement Disorder Society|January 12, 2019
The usual suspects, dopamine and alpha-synuclein, conspire to cause neurodegenerationDanielle E Mor, Malcolm J Daniels, Harry Ischiropoulos
Neurobiology of Disease|January 10, 2016
Dynamic structural flexibility of α-synucleinDanielle E Mor, Scott E Ugras, Malcolm J Daniels, et al.
Communications Biology|February 16, 2021
High-throughput behavioral screen in C. elegans reveals Parkinson's disease drug candidatesSalman Sohrabi, Danielle E Mor, Rachel Kaletsky, et al.
Life Science Alliance|July 5, 2022
Heparan sulfate proteoglycans mediate prion-like α-synuclein toxicity in Parkinson's in vivo modelsMerry Chen, Julie Vincent, Alexis Ezeanii, et al.
Pageof 2